Home > EMCDDA–Europol Joint report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone).

Europol, European Monitoring Centre for Drugs and Drug Addiction. (2014) EMCDDA–Europol Joint report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone). Lisbon: European Monitoring Centre for Drugs and Drug Addiction & EUROPOL.

[img] PDF (Report on a new psychoactive substance: methoxetamine) - Published Version
681kB

The EMCDDA–Europol Joint Report on new psychoactive substance methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and Europol concluded that sufficient information had been accumulated to merit the production of a Joint Report on methoxetamine as stipulated by Article 5.1 of the Decision.

Common names or codenames that have also been reported are: 3-MeO-2-Oxo-PCE, MXE, MXE100 and metoksetamiini (Finnish).

The following street names have also been reported: ‘MXE’, ‘Mexxy’, ‘M-ket’, ‘MEX’, ‘Kmax’, ‘Special M’, ‘MA’, ‘legal ketamine’, ‘Minx’, ‘Jipper’ and ‘Roflcoptr’.

Finally, the following ‘legal high’ product names have been associated with methoxetamine: ‘Kwasqik’, ‘Hypnotic’, ‘Panoramix’, ‘Magic’, ‘Lotus’, ‘Special K’ and ‘X’.


Date:January 2014
Pages:40 p.
Publisher:European Monitoring Centre for Drugs and Drug Addiction & EUROPOL
Corporate Creators:Europol, European Monitoring Centre for Drugs and Drug Addiction
Place of Publication:Lisbon
EndNote:View
Accession Number:HRB (Electronic Only)
Related URLs:
Subjects:B Drugs and alcohol substances > New (novel) psychoactive substances
VA Geographic area > Europe

Repository Staff Only: item control page